We have located links that may give you full text access.
English Abstract
Journal Article
[Botulinum toxin as a treatment for strabismus in systemic diseases].
Archivos de la Sociedad Española de Oftalmología 2003 January
PURPOSE: To demonstrate the effectiveness of botulinum toxin for treating strabismus secondary to systemic diseases.
MATERIAL AND METHODS: 141 patients with secondary strabismus were studied. To reduce risks, the treatment with botulinum toxin was made by a direct technique proposed by the authors. The response to the treatment was classified according to the different physiopathogenic groups.
RESULTS: We found a positive response in: Central Neurological damage: 71%, Endocrinopathies: 78.6%, Brain infection: 80%, Trauma: 60%, Psychomotor defficiency: 72%, Prematurity: 74%, Myasthenia 75%, Hemathological diseases: 75%. The average of botulinum toxin applications was 1.5 infections.
CONCLUSIONS: We show that the effectiveness of botulinum toxin in strabismus secondary to systemic disease is up to 74%. We can offer rehabilitation in all of these cases even during the sometimes long diagnostic period or in patients under treatment. We also suggest our direct technique for the application of botulinum toxin (without electromyography) to avoid risks in this type of patients. We are reporting the use and positive effect of the botulinum toxin chemodenervation in Myasthenia gravis, Human Acquired Immune-deficiency Syndrome, and mental defficiency.
MATERIAL AND METHODS: 141 patients with secondary strabismus were studied. To reduce risks, the treatment with botulinum toxin was made by a direct technique proposed by the authors. The response to the treatment was classified according to the different physiopathogenic groups.
RESULTS: We found a positive response in: Central Neurological damage: 71%, Endocrinopathies: 78.6%, Brain infection: 80%, Trauma: 60%, Psychomotor defficiency: 72%, Prematurity: 74%, Myasthenia 75%, Hemathological diseases: 75%. The average of botulinum toxin applications was 1.5 infections.
CONCLUSIONS: We show that the effectiveness of botulinum toxin in strabismus secondary to systemic disease is up to 74%. We can offer rehabilitation in all of these cases even during the sometimes long diagnostic period or in patients under treatment. We also suggest our direct technique for the application of botulinum toxin (without electromyography) to avoid risks in this type of patients. We are reporting the use and positive effect of the botulinum toxin chemodenervation in Myasthenia gravis, Human Acquired Immune-deficiency Syndrome, and mental defficiency.
Full text links
Related Resources
Trending Papers
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Review article: Recent advances in ascites and acute kidney injury management in cirrhosis.Alimentary Pharmacology & Therapeutics 2024 March 26
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app